BackNemaura Medical Overview

Nemaura Medical Profit Margin

Valuation check: NMRD's profit margin is 405.33%, above the Healthcare sector average of 13.89%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Dec 2023

Annual Profit Margin (TTM)

405.33%
108.21% YoY

Trailing 12 months ending Dec 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Nemaura Medical (NMRD) FAQ

Nemaura Medical (NMRD) currently reports a profit margin of 405.33% as of December 2023. That compares with -4938.27% in the prior-year period — up 108.2% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Nemaura Medical's profit margin history and peer comparisons.

Nemaura Medical's profit margin increased from -4938.27% to 405.33% — a 108.2% year-over-year increase (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nemaura Medical's profit margin of 405.33% is higher than the Healthcare sector average of 13.89%. That is roughly 2817.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nemaura Medical's current 405.33% should be judged against Healthcare norms (sector average: 13.89%) and against NMRD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 405.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Nemaura Medical, and consider following NMRD for alerts when major investors trade the stock.